Drug-resistant bronchial asthma successfully treated with plasma exchange

Area of Science:

• Allergy and Immunology
• Pulmonology
• Nephrology (Therapeutic Apheresis)

Background:

• Allergic bronchial asthma is a chronic respiratory condition often managed with pharmacotherapy.
• Refractory cases of severe allergic asthma pose significant treatment challenges.

Observation:

• Two patients with severe allergic bronchial asthma showed no improvement after prolonged conventional drug therapy.
• These patients were subsequently treated with therapeutic plasma exchange.

Findings:

• Both patients experienced a complete resolution of asthma attacks following therapeutic plasma exchange.
• One patient remained symptom-free for five months, and the other for over a year.

Implications:

• Therapeutic plasma exchange may be a valuable treatment option for severe, drug-resistant allergic bronchial asthma.
• The procedure rapidly removes immunocomplexes and antigens, directly intervening in the disease's pathomechanism.
• Further research is warranted to confirm the efficacy and long-term benefits of this approach.